Mangrove Partners’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-499,951
Closed -$5.13M – 294
2022
Q4
$5.13M Buy
+499,951
New +$32K 0.29% 97
2022
Q3
– Sell
-200,050
Closed -$1.98M – 429
2022
Q2
$1.98M Buy
+200,050
New +$47.5K 0.1% 313

Other funds holding HAIAW

Mangrove Partners's HAIAW Position: Q1 2023 in Review

Mangrove Partners sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q1 2023, closing a stake of 499,951 shares — an estimated $5.13M sold.

Mangrove Partners first reported a position in HAIAW in Q2 2022 and held it in 2 quarters. The position peaked at $5.13M in Q4 2022. 43 funds tracked by Wall St. Rank hold HAIAW as of Q1 2023.

  • Mangrove Partners reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q1 2023 after selling out during the quarter.
  • Mangrove Partners sold 499,951 Healthcare AI Acquisition Corp. Warrants shares in Q1 2023, an estimated $5.13M.
  • Mangrove Partners first reported a position in Healthcare AI Acquisition Corp. Warrants in Q2 2022 and held it in 2 quarters.
  • Mangrove Partners's Healthcare AI Acquisition Corp. Warrants position peaked at $5.13M in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.